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Abstract
Antigenic variation of major surface proteins is considered an immune-evasive maneuver used by pathogens as divergent
as bacteria and protozoa. Likewise, major surface protein 2 (Msp2) of the tick-borne pathogen, Anaplasma marginale,i s
thought to be involved in antigenic variation to evade the mammalian host immune response. However, this dynamic
process also works in the tick vector in the absence of immune selection pressure. We examined Msp2 variants expressed
during infection of four tick and two mammalian cell-lines to determine if the presence of certain variants correlated with
specific host cell types. Anaplasma marginale colonies differed in their development and appearance in each of the cell lines
(P,0.001). Using Western blots probed with two Msp2-monospecific and one Msp2-monoclonal antibodies, we detected
expression of variants with differences in molecular weight. Immunofluorescence-assay revealed that specific antibodies
bound from 25 to 60% of colonies, depending on the host cell-line (P,0.001). Molecular analysis of cloned variant-encoding
genes demonstrated expression of different predominant variants in tick (V1) and mammalian (V2) cell-lines. Analysis of the
putative secondary structure of the variants revealed a change in structure when A. marginale was transferred from one cell-
type to another, suggesting that the expression of particular Msp2 variants depended on the cell-type (tick or mammalian)
in which A. marginale developed. Similarly, analysis of the putative secondary structure of over 200 Msp2 variants from ticks,
blood samples, and other mammalian cells available in GenBank showed the predominance of a specific structure during
infection of a host type (tick versus blood sample), demonstrating that selection of a possible structure also occurred in vivo.
The selection of a specific structure in surface proteins may indicate that Msp2 fulfils an important role in infection and
adaptation to diverse host systems. Supplemental Abstract in Spanish (File S1) is provided.
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Introduction
Several bacterial pathogens survive the complex mammalian
adaptive immune system by changing their surface protein [1,2].
This results in the establishment of persistent infection, enhancing
their transmission to a susceptible host [3]. Anaplasma marginale is a
tick-borne, obligate intracellular x-proteobacterium in the order
Rickettsiales, family Anaplasmataceae, that causes bovine ana-
plasmosis [4]. This pathogen utilizes a recombinatorial mechanism
of antigenic variation in which different variants of the immu-
nodominant major surface protein 2 (Msp2) are expressed during
different phases of infection [2,5,6]. The course of disease is
characterized by cyclical parasitemic peaks that follow the primary
infection and persist during the life of the animal. These cycles in
the infection are the result of the recognition and clearance of
bacteria expressing a Msp2 variant by variant-specific host
antibodies and the subsequent emergence of new variants [7–
10]. Both A. marginale and the closely related A. phagocytophilum, the
causative agent of human granulocytic anaplasmosis, possess a
polycistronic expression locus that encodes the single msp2 expression
cassette [11]. Dispersed throughout the chromosome, A. marginale
encodes 7–12 msp2 donor alleles (also referred as pseudogenes) with
conserved regions flanking a central hypervariable region (HVR)
[10]. In the early stages of disease, simplevariants arise by duplication
of an entire donor allele from the non-expressed site in the
chromosome into the expression cassette. As infection continues,
portions of multiple msp2 donor alleles are recombined into the
expression cassette by a gene conversion mechanism [2,8,10]. This
last step results in a ‘‘mosaic’’ representing HVR sections of two or
more donor alleles in the HVR of the expressed copy [10,12].
Even though antigenic variation of this protein has primarily
been associated with evasion of the immune response, msp2
undergoes variation in the absence of immune selection within the
tick vector [13–17]. Several authors have proposed that selection
for new variants occurs in the tick after the blood meal and that
some of these variants are unique to specific tissues, e.g. the
salivary gland variants [15–17].
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lum, has been shown to respond to changes in the environment in
which the bacteria develop, i.e., in tick or mammalian cells [11].
Specific variants of msp2(p44) developed within 3 weeks of
transferring the organism from mammalian cells to tick cells or
vice versa. It has been suggested that A. phagocytophilum Msp2/P44
acts as a porin to facilitate acquisition of metabolites from the host
cell [18]. It is possible that its homolog, Msp2, fulfils a similar role
in A. marginale. Species- and tissue-specific differences in cell
membrane structure could account for adaptive changes necessary
to maintain function of the porin in the mammalian and tick
tissues in which Anaplasma species replicate during completion of
their life cycle. Antigenically variable proteins have been shown to
be involved in tissue tropism in other bacteria, as in the case of
VlsE in Borrelia spp. that is highly expressed during infection of
mammalian cells (reviewed in [19]).
Palmer et al [6] proposed that selection for simple variants
provided a fitness advantage to the organism when replicating
in naı ¨ve animals and the tick vector. Generation of simple variants
occurred within the first week of infection in naı ¨ve animals at a
time when the immune system presumably had not yet
encountered the complete repertoire of antigens encoded by
genomic donor alleles. Donor alleles may undergo specific
evolutionary selection for growth fitness [6] with certain variants
preferentially expressed during early stages of acute infection. For
example, 29% of the variants recovered during acute infection
presented intact Msp2y1HVR or Msp2y1HVR containing a
segmental change in its coding sequence [20].
We studied the variation of Msp2 during infection of different
tick and mammalian cell lines with the A. marginale strain Virginia
(A. marginale VA) using serologic and molecular approaches to
determine if the host cell environment influenced expression of
distinct variants. Herein, we report differences in development and
morphology of A. marginale VA colonies in tick cell lines derived
from different species that are competent natural or experimental
vectors, and in two mammalian cell lines that support replication
of A. marginale VA [21]. We discuss the possibility that these
differences are linked to Msp2 variation as an adaptation to
survival in distinct environments. We describe preferential
expression of certain Msp2 variants during infection of specific
host cells, similar to what has been observed with expression of
Msp2/P44 in A. phagocytophilum [11,13,20], and selection for
different conformational structures during infection of specific host
cell types in vitro and in vivo. The preferential expression of certain
Msp2 variants with specific structures in different host cells
suggests that this protein may be involved in important
interactions between A. marginale and its host cell.
Materials and Methods
A. marginale VA growth in cultured cells
For our studies on Msp2 expression, the A. marginale VA [22]
was cultured in four tick cell lines at 34uC and two mammalian cell
lines at 37uC in tightly capped flasks. The tick cell lines used were
BME26 [23] derived from embryonated eggs of the southern cattle
tick, Rhipicephalus (Boophilus) microplus (Canestrini), ISE6 [24] and
IDE12 [25] derived from embryonated eggs of the blacklegged
tick, Ixodes scapularis (Say), and DAE100T [26] from embryonated
eggs of the Rocky Mountain wood tick, Dermacentor andersoni (Stiles).
The mammalian cells used in this research were Vero (ATCC
CCL-81 from kidney epithelial cells of an African Green monkey,
Cercopithecus aethiops) and RF/6A cells (ATCC CRL-1780 from
retina choroid endothelium of a rhesus monkey, Macaca mulatta).
Uninfected tick cell cultures were inoculated with A. marginale VA
[21] from ISE6 cells at passage 50, and mammalian cell lines were
inoculated with cell free A. marginale VA purified from ISE6 cells at
passage 46 [27]. Cell cultures were maintained in L15B300
medium as described previously [28].
Bovine blood stabilates of A. marginale VA used for msp2
characterization
Frozen blood stabilate from a splenectomised calf, PA291,
infected with A. marginale VA was regenerated from liquid nitrogen
[21]. For comparison we used a second frozen blood stabilate
taken from an infected 3 months old splenectomised Hereford calf,
PA344, that had been inoculated with A. marginale VA grown in the
I. scapularis cell line IDE8 [21]. A detailed description of the blood
stabilates can be found in Materials and Methods S1. Frozen
blood was rapidly thawed (37uC water bath), transferred to a
15 ml tube containing 10 ml L15B medium and gently mixed.
The cell suspension was centrifuged at 20006g for 10 min to
remove DMSO and plasma. The cell pellet was resuspended in
10 ml L15B medium and the cells were washed twice more by
centrifugation at 20006g for 10 min. DNA was extracted from the
cell fraction as described below (Cloning and analysis of msp2 variants
expressed in vitro and in vivo).
Anaplasma culture and evaluation of differences in
development
After 5–6 passages of the bacteria in each of the cell lines,
differences in the replication of A. marginale VA were assessed by
measuring changes in the rate of cell-to-cell spread of the bacteria
(infection rate). Infection rate was calculated as the slope of the
linear regression line fitted to the percent infected cells at different
time points from day 3 until the culture reached $90% infection (3,
5, 7, and 12 days post-inoculation, and at subculture). Cultures were
monitored by light microscopic observation of Giemsa-stained cells
[21] and the percent infected cells at eachtime point was determined
by counting a total of 300 cells in four replicates (each replicate
representing a separate infected culture) per cell line. Statistical
differences in growth rates were evaluated using Repeated Measures
ANOVAwithSigmaPlot(SystatSoftware,Inc.,SanJose ´,California).
Western blots
Expression of Msp2 variants during infection of the different cell
lines was analyzed by Western blotting. Protein was extracted from
cell free bacteria purified from each cell line [27], and negative
controls consisted of proteins extracted from uninfected IDE12
and ISE6 cells. Proteins were resolved by electrophoresis through
polyacrylamide gels, and blotted onto membranes [27]. Blots were
incubated with various Msp2 specific antibodies (Table 1) diluted
in PBS with 3% bovine serum albumin overnight at 6uC, washed
four times in PBS, and labelled with anti-rabbit or anti-mouse IgG
conjugated to horseradish peroxidase, as required. Blots were
developed with the ImmunoPureH metal enhanced DAB substrate
(Pierce, Rockford, Illinois) system. Additional details about the
methods used are explained in Materials and Methods S1.
Immuno-fluorescence assay (IFA)
Samples from triplicate cultures infected with A. marginale VA at
50% were spun onto microscope slides, and cell spots were then
processed for IFA [28]. Uninfected cells and infected cells not
exposed to primary antibody served as controls. The slides were
dried, the cell spots were counter-stained with Evan’s blue
(0.0005%) and covered with VectaShield mounting medium with
49-6-Diamidino-2-phenylindole (DAPI) (Vector laboratories, Bur-
lingame, California). DAPI was used to stain DNA from all A.
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bound a specific antibody was determined by counting 100
infected cells (counted using the host nuclei). Two-way ANOVA
(SigmaPlot; Systat Software, Inc., San Jose ´, California) was carried
out to evaluate the significance of the differences in antibody
binding between A. marginale VA growing in the various cell lines.
A detailed description of the procedures used for IFAs is given in
Materials and Methods S1.
Cloning and analysis of msp2 variants expressed in vitro
and in vivo
After approximately 20 continuous passages in the same cell
line, host cell-free A. marginale VA were harvested from cells grown
in 25-cm
2 flasks and bacterial DNA was extracted according to the
tissue culture protocol of the Gentra Puregene genomic DNA kit
[27] (Qiagen, Valencia, California). To confirm infection, A.
marginale VA was PCR-amplified using primers listed in Table 2.
Additionally, we extracted DNA from the previously mentioned
blood samples. DNA from infected bovine blood (PA291 and
PA344) was extracted following the whole blood protocol of the
Gentra Puregene DNA kit. PA291 DNA was additionally treated
with GeneReleaser, according to manufacturer’s specifications
(BioVentures Inc., Murfreesboro, Tennessee). More information
about the blood samples is provided in Materials and Methods S1.
The msp2 gene copy in the expression cassette was amplified
using PCR with primers listed in Table 2 and under conditions
described in Materials and Methods S1 [29]. Amplified products
were cloned into pCR4H-TOPO (Invitrogen, Grand Island, New
York). A total of 120 clones from each cell line and blood sample
were isolated and sequenced to analyze predominant and rare
variants. For comparison, variants from A. marginale VA passage 46
in ISE6 cells (the passage used as starting inoculum for cultivation
in mammalian cells) were analyzed the same way. Thirty clones
were analyzed from this sample which provided .90% probability
of detecting variants present in the population at greater than 5%
[6]. Nucleotide sequences were analyzed and translated into
amino acid sequences using MacVector 10.6 (MacVector Inc.,
Cary, North Carolina) and Sequencher 4.8 (Gene Codes
Corporation, Ann Arbor, Michigan). The hypervriable regions
(HVR) of the amino acid sequences were aligned and compared
using ClustalW [30]. The predominant variant of each cell line
was determined as described in Material and Methods S1.
Table 1. Antibodies used to serologically determine the variation of Msp2 in the different tick and mammalian cell lines.
Antibody Type and specificity Description Dilution for western blot Dilution for IFA Reference
VMRD O50A2 Monoclonal anti-Msp2 Mouse IgG1. Capable of recognizing
variants shared between different
isolates
1:200 1:100 McGuire et al. (1984)
R883 Mono-specific anti-Msp2 Rabbit isotype not known. Animal
inoculated with whole Msp2 from
Florida isolate
1:1000 1:500 Palmer et al. (1988)
R884 Mono-specific anti-Msp2 Rabbit isotype not known. Animal
inoculated with whole Msp2 from
Florida isolate
1:1000 1:500 Palmer et al. (1988)
doi:10.1371/journal.pone.0036012.t001
Table 2. Primers used for the confirmation of A. marginale infection, PCR amplification of Msp2 variants, and Msp2 expression qRT-
PCR analysis.
Primer Specificity Gene target Product size Nucleotide sequence Ref
(bp)
Anaplasma 16 s rRNA 451 PER1 59-TTT ATC GCT ATT AGA TGA GCC TAT G-39 Goodman et al., 1996
or Ehrlichia PER2 59-CTC TAC ACT AGG AAT TCC GCT AT-39
A. marginale msp1b 407 BAP-2 59-GTA TGG CAC GTA GTC TTG GGA TCA-39 Stich et al., 1993
AL34S 59-CAG CAG CAG CAA GAC CTT CA-39
A. marginale msp2 1,125 For 59-TCC TAC CAA GAG TCT TTT CCC C-39 Futse et al., 2005
expression Rev 59-TTA CCA CCG ATA CCA GCA CAA-39
A. marginale msp2 HVR ,366 qRT-PCRf 59-AGT ATT GGA GGA GCC AGG GT-39 Herein
qRT-PCRr 59-GTC CAT TGA CGA TAT GGC CT-39
A. marginale RNA polymerase 282 Forward 59-CGA ACT CAG GAA ACT GCT CC-39 Herein
Reverse 59- AAA TTG TGC TTA ACC GCC AC-39
A. marginale 16 s rRNA 193 Forward 59-TCT TAA CAG AAG GGC GCA GT-39 Herein
Reverse 59- GAC TTG ACA TCA TCC CCA CC-39
A. marginale 23 s rRNA 172 Forward 59-CCG GTG CTG GAA GGT TAA TA-39 Herein
Reverse 59-AAT TTC GCT GAG TCG ATG CT-39
doi:10.1371/journal.pone.0036012.t002
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ticks, tick cells, and blood samples from acute and persistently
infected animals infected with A. marginale VA, South Idaho, or
Oklahoma strains [13,17,31] were compared with the sequences
recovered in this study. The sequences of the msp2 donor alleles of A.
marginale VA and South Idaho strains [32] were included in the
phylogenetic analysis of all the variants. Variant amino acid
sequences were trimmed to contain only the HVR sequence and
subjected to phylogenetic analysis using the total number of
differences in MEGA 4.0 and Neighbor-Joining with 3000 bootstrap
replicates to examine the relationship of variants to each other.
Determination of msp2 donor allele repertoires
Genomic DNA was extracted from A. marginale VA infected
blood using the Gentra Puregene DNA isolation kit (Qiagen). As
previous studies have indicated that the A. marginale msp2 allelic
repertoires are positionally conserved between strains [33], we
employed a locus specific PCR strategy using eight locus specific
primer sets designated: P1, y1, y2, G11, 3H1, E6F7, 9H1, and
TTV106 (Table 3). The PCR Master kit (Roche, Indianapolis,
Indiana) was used as follows: 30 cycles of melting at 94uC for 30 s,
variable annealing temperature for 30 s, and extension at 72uC
(annealing temperatures and extension times are shown in
Table 3). The PCR amplicons were ligated into the pCR4-
TOPO vector using the TOPO-TA cloning kit (Invitrogen, Grand
Island, New York), and then transformed into TOP10 E. coli cells.
DNA was extracted by using the Wizard plus SV Miniprep DNA
purification system (Promega, Madison, Wisconsin). The plasmid
DNA was sequenced with the Big Dye kit (Applied Biosystems,
Carlsbad, California). Inserts for the P1, G11, 9H1, and TTV106
loci were sequenced using HV univ for and HV univ rev primers
[34], and 3H1, E6F7, y1, and y2 were sequenced using T3 and
T7 primers. The A. marginale VA donor alleles have been deposited
in GenBank with accession numbers VaP1: JN703159, VaG11:
JN703155, Va9H1: JN703157, Va3H1: JN703158, VaE6F7:
JN703156, Vay1: JN703161, and Vay2: JN703160 and
VaTTV106: JN703154.
Bioinformatic and complexity analysis of Msp2 variants
Several parameters including charge, amino acid composition,
and grand average of hydropathicity (GRAVY) were analyzed
using ProtParam from the ExPASy proteomics server (www.
expasy.ch/tools/protparam.html). The secondary structure of the
variants was predicted using Psipred (http://bioinf.cs.ucl.ac.uk/
psipred/) [35] and the Chou-Fasman method from MacVectorH.
The differences in structure between variants and their frequency
was analysed to determine if patterns in variation coincided with
changes in the potential secondary structure.
Additionally, complexity scores and donor allele usage for each
of the cell lines and blood samples were determined [20,29].
Preferential donor allele usage was evaluated by determining the
frequency of recombination of whole or segments of specific donor
alleles during production of new variants [20]. We additionally
calculated the differences in donor allele usage within a population
by comparing the predominance of all the variants containing
complete or partial sequences of a particular donor allele’s HVR.
The predominance of the variants was calculated as described in
the section Cloning and analysis of msp2 variants expressed in vitro and in
vivo and in Materials and Methods S1. Significance was evaluated
using chi-square.
Analysis of differences in msp2 expression by qRT-PCR
RNA from A. marginale VA grown in ISE6, DAE100T, and RF/
6A cells was extracted using the Absolutely RNA miniprep kit
(Stratagene, La Jolla, California) and treated with Turbo DNA-
free DNase (Ambion, Austin, Texas) to eliminate any remaining
DNA. qRT-PCR was performed using primers Msp2f and Msp2r
(Table 2), that are complementary to the conserved flanking
regions of msp2 at positions 4798–4817 bp and 5163–5144,
respectively, of the A. marginale VA msp2 operon GenBank
accession number: AY132312). msp2 expression was normalized
against expression of RNA polymerase (rpoB) and 16 s rRNA genes
using the comparative Ct method [36]. All reactions were
performed in a Stratagene Mx3005 QPCR machine using the
Brilliant II SYBR green QRT-PCR Master Mix 1-Step kit
Table 3. Primers used for the amplification of A. marginale pseudogenes.
msp2 pseudogene Primer sequence Annealing temp (6C) Extension (mins)
P1 P1 F1 59- GTGGTTCCTGGGGTACATCTAGTATAGG-39 60 4
P1 Rx 59- CTAGTCGCTGTATCATCAGCTTCAGTAC-39
G11 G11 Fx 59- GCGACCAAACACAGCACATCCG-39 60 4
G11 Rx 59- CAGAGCGGCGTTGCCTTGTC- 39
3H1 3H1 Fx 59- CAGTCTCTTGTACCTCAACACC- 39 57 2
3H1 Rx 59- CTTGGTAGCTGTATCGTCAGC- 39
E6F7 E6F7 Fx 59- GGCCGGCAAGGTCAGCATAAGCTGTGG- 39 57 2
E6F7 Rx 59- CTCGTATGACTGGCACAGTCAAACTTAC- 39
y1 y1F x5 9– CACCACCACTGCTACCAGTC– 39 58 1
y1R x5 9– GCCCAATCTGCTACCACCTCTG– 39
y2 y2F x5 9– CTTGGCCTACCAAATCTCGACCCTG– 39 58 1
y2R x5 9– CCCAGTTCCCACTTACCAGCACC– 39
9H1 9H1 Fx 59- GCTCGCCAATCAACAACGTGTTCAC- 39 57 2
9H1 Rx 59- CGCATCTTTGCCAATCTGGGTATTCC- 39
TTV106 TTV106 Fx 59- GACGCATATACCTTGGCTCACCGTTC- 39 58 2.5
TTV106 Rx 59- GTGCAGCACTACGGTGTTGGTGTG C- 39
doi:10.1371/journal.pone.0036012.t003
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200 nM, 30 nM ROX (as reference dye), and 100 ng of total
RNA. Cycling conditions were as follow: an initial step of reverse
transcription for 30 min at 50uC, followed by a denaturing step of
10 min at 95uC, and 40 cycles with denaturing at 95uC for
30 seconds, an annealing temperature of 63uC for 1 min, and
extension at 72uC for 1 min, with a final denaturing step at 95uC
and annealing for 30 seconds at 63uC to determine the
dissociation curve. Statistical significance of gene expression
results was evaluated using REST 2008 [37] (http://www.
gene-quantification.de/rest-2008.html), with 2000 randomiza-
tions.
Accession numbers for Msp2 variants
The predominant msp2 variant from tick cell lines was
designated as V1 (EU496530), whereas the predominant variant
from mammalian cells was designated as V2 (EU496531), the msp2
variant shared among tick cell lines only was designated V4
(EU496533), and variants shared between the mammalian and tick
systems were designated V3 (EU496532) and V5–V12 (JQ082310,
EU512243, EU496534, EU517681, EU499673, JQ177150,
EU499670). Variants shared between blood samples were desig-
nated V13 (EU627153) and V14 (EU627154). msp2 variants unique
to the tick cell line ISE6 were assigned codes V15 to V17
(EU496539, JQ082308, JQ082309). Variants unique to BME26,
DAE100T and IDE12 cells were coded V18 to V21 (EU496538,
EU496536, JQ082306, JQ082307), V22 to V26 (JQ177151–
JQ177155), and V27 to V31 (EU499671, EU499672, JQ177156,
JQ177157) respectively. Variants unique to the mammalian cell
lines Vero and RF/6A were coded V32 to V36 (EU512244–
EU512248), and V38 to V41 (EU517678, EU517679, EU512237,
EU512238), respectively. msp2 variants from PA344 were
assigned codes V42 to V74 (EU517683–EU517694, EU526866–
EU526882), and variants from PA291 were given the codes V75 to
V97 (EU526883–EU526897, EU627148–EU627155). GenBank
accession numbers are given in parentheses.
Results
A. marginale development in the different cell lines
A. marginale VA invaded and infected all the tick and
mammalian cell lines, replicating in intracellular inclusions as
previously reported [21,28,38]. Infection rates of A. marginale VA in
each of the cell lines differed significally (P,0.001). Infection rates
in I. scapularis cell lines were higher (6.4% and 5.1% increase in
infected cells per day) compared to the other tick cell lines (4.9%–
3.4%) (Table 4 and Figure 1G). In both I. scapularis cell lines,
.90% of the cells were infected by 7 to 12 days after inoculation,
and growth was slowest in mammalian cell lines, while infection
rates were intermediate in R. microplus and D. andersoni cell lines
(Table 4; Figure 1G). In mammalian cells A. marginale grew more
slowly than in tick cells (Table 4; Figure 1G) and approximately 3
weeks elapsed before 80 to .90% infection was reached. These
results may mirror the natural behavior of A. marginale, which
spreads quickly through tick tissues, but develops slowly in cattle.
Male D. andersoni were infectious one week following acquisition
feeding, while calves developed anaplasmosis 3.5 weeks later [39].
The closely related A. phagocytophilum likewise requires long periods
of adaptation when transferred from tick to mammalian cell
cultures. The transitional period is accompanied by recombination
of different msp2/p44 paralogs into the expression locus, resulting
in a heterologous population of bacteria that display predomi-
nance of certain variants in a manner similar to that described
here for A. marginale VA [11].
Light microscopic examination of infected cells showed that
colony morphology also varied greatly from cell line to cell line. In
both mammalian cell lines A. marginale VA developed into several
small colonies that filled most of the cell (Figure 1A and 1E). In
DAE100T and IDE12 cells the bacteria similarly produced four or
more small colonies (Figure 1B and 1F, respectively), whereas in
BME26 and ISE6 cells contained one to three large colonies
(Figure 1C and 1D, respectively).
Msp2 expression patterns
Western blots probed with different monoclonal and monospe-
cific antibodies revealed variability in the molecular weight of
Msp2s expressed during growth of A. marginale VA in the different
cell lines. The most prominent bands spanned a range of 36 to
44 kDa, which is consistent with the molecular weight previously
reported for Msp2 [40]. Blots probed with monoclonal (mAb) and
monospecific antibodies (msAb) identified several Msp2 variants
expressed in different cell lines. In A. marginale VA proteins from
BME26 cultures the Msp2 msAb R883 detected two small bands,
whereas a blot of the same sample when probed with mAb O50A2
showed a single prominent band of different molecular weight
(Figure 2A). A. marginale VA replicating in BME26 cells lacked
expression of Msp2 variants that are recognized by these
antibodies. However, R883 msAb detected two minor variants
in the BME26 sample, one of which was similar in size to a minor
variant detected in the population grown in IDE12. R884 msAb
detected different sized variants in BME26 and DAE100T and an
additional variant not detected in other samples (Figure 2A).
Analysis of Msp2 variant expression in A. marginale VA colonies
by IFA revealed a cell type dependent pattern. Statistical analysis
demonstrated significant differences in the ability of antibodies to
recognize colonies in cell lines (P=0.023) as well as differences in
the percentage of colonies labelled by different antibodies in a
specific cell line (P,0.001) (Figure 2B). The greatest differences
were apparent in the percentage of colonies in different cell lines
that were recognized by a particular antibody. These monoclonal
and mono-specific antibodies likely bind to a specific variant or
different set of variants, respectively expressed in the cell lines.
R884 msAb labelled to up to 60% of the colonies in Vero cells
compared to around 25% in BME26 and 30% in IDE12 and
DAE100T (Figure 2B). Similarly, R883 showed significant
variability with around 75% of the colonies recognized in Vero
cells versus only 50% in ISE6. In contrast, mAb O5A02 recognized
5–15% more colonies in mammalian than in tick cells, depending
on the cell line, however, these differences were not statistically
significant (Figure 2B).
Table 4. Growth rates differences during infection of various
tick and mammalian cell lines.
Cell line Infection rate R value P value
(IC/day*)
ISE6 6.441 0.908 ,0.001
IDE12 5.12 0.83 ,0.001
BME26 3.398 0.683 0.004
DAE100T 4.877 0.724 0.002
Vero 2.096 0.78 ,0.001
RF/6A 3.102 0.887 ,0.001
*IC/day=Infected cells increase per day.
doi:10.1371/journal.pone.0036012.t004
Anaplasma Marginale Msp2 Variants
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cell types
Clones harbouring the sequence amplified from the msp2
expression locus in each cell line were sequenced and translated
into amino acid (aa) sequences for molecular analysis of Msp2
variation. The HVR portions (180–290 aa) of Msp2 [7] from all
clones were aligned and the number of clones of the total 120
clones analyzed for each cell line and blood sample that presented
an identical sequence was used to estimate the predominance of a
variant in the mixed population. An alignment of aa sequences in
variants predominating in mammalian (V2) and tick (V1) cell
cultures and blood from two infected animals (V96 in PA291, V57
in PA344) is shown in Figure 3. Changes in the constant regions
were used to estimate sequencing errors [13], and only those
HVRs with ,97% identity were classified as unique. All tick cell
lines shared the same predominant variant (designated V1) that
was present in 86%, 76%, 73%, and 68% of the clones from ISE6,
BME26, IDE12, and DAE100T, respectively (Figure 4A). This
same variant (V1) was also recovered from the original inoculum
(A. marginale VA passage 46) and was the predominant variant
before inoculation into tick and mammalian cell lines. V1 was also
recovered from mammalian cells but with lower frequency (8%
from RF/6A and 13% from Vero cells) (Figure 4B). V1 differed by
9 aa changes from the predominant variant found in mammalian
cells (V2), which corresponds to a segmental change: the V2 HVR
is identical to donor allele VaE6F7, and V1 contains a segment
from Vay2 recombined onto this template (Figure 3). V2 was
present in blood, tick and mammalian cells (Figure 4A–C),
representing 83% and 70% of the clones recovered from RF/6A
and Vero cells, respectively, but only 4% to 11% of the clones
recovered from populations in the tick cell lines.
Variants V1 and V2 differed from the predominant variants
found in the blood samples PA291 and PA344 by 29 to 33 aa
changes, respectively (Figure 3). Interestingly, V2 was present in
both PA291 and PA344 blood samples (Figure 4C), whereas V1
was only found in the sample from Hereford calf PA344 that had
been inoculated with A. marginale VA grown in IDE8 tick cells,
albeit at low frequency (3.3%) (Figure 4C). The presence of V2 in
both samples indicates that this variant may be more suited for the
mammalian environment, whereas the lack of V1 in PA291 could
reflect that this animal was inoculated with infected blood and thus
this variant was probably absent from the inoculum. None of the
predominant variants found in the blood samples (V57 and V96)
were present in the tick or mammalian cell cultures, suggesting
they were generated through immune pressure, and only blood
variants with minor frequency (V8 and V3) were shared with some
but not all of the cell lines (Figures 4C).
Figure 1. Differences in colony morphology and percentages of
infection during in vitro replication in cell lines. Giemsa stained
preparations show the colony morphology of A. marginale VA in (A)
Vero cells, (B) DAE100T cells, (C) BME26 cells, (D) ISE6 cells, (E) RF/6A
cells, and (F) IDE12 cells. Arrows point to the A. marginale VA colonies
growing in each cell line. Cell nuclei stained in lighter red-purple color
and marked with the letter n. Bar=20 mm. (G) Increase in the percent of
infected tick and mammalian cells during a 12-day period. The solid red
line with red circles represent the infection rate of ISE6 cells at each
time point. The solid blue line and blue circles represent IDE12. Solid
black line and triangles represent to the infection rates in BME26 cells,
whereas the green squares and line represent to the values for the
infection rates in Vero cells. The linear regression calculated from the
percent infected cells over time is shown as a dotted line in the color
corresponding to the cell line represented.Bars represent the standard
deviation for each time point.
doi:10.1371/journal.pone.0036012.g001
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cell line and blood sample. The greatest number of variants was
found in the blood from the acutely infected animal PA344 (38
variants), followed by the blood sample from PA291 from which
we obtained 26 variants (Figure 4C). Variation during culture was
highly reduced and the total number of variants present in tick
cells differed among cell lines (7–11 variants) (Figure 4A). A.
marginale VA from I. scapularis cell lines supported the fewest
variants, i.e., there were only seven variants in ISE6 and eight in
IDE12, whereas BME26 had nine and DAE100T cells presented
ten (Figure 4A). By comparison, we detected 11 variants in Vero
and 10 in RF/6A cell lines (Figure 4B). Interestingly, many of the
minor variants found in each cell line were unique to that specific
line (Figure 4A–B). The number of unique variants was highest in
the two blood samples, PA291 (22) and PA344 (32) (Figure 4C),
but new variants were also generated during in vitro culture in the
absence of immune pressure. Bacteria growing in tick cell lines
produced a total of 15 unique variants (Figure 4C) with the IDE12
cell line showing the highest number of unique variants (5)
(Figure 4A). On the other hand, mammalian cells presented 9
unique variants, with 5 unique variants in Vero cells and 4 in RF/
6A cells (Figure 4B).
Analysis of variation in vivo and in vitro
In order to place our variants in the context of msp2 donor
alleles and expressed variants from other sources, we undertook a
phylogenetic analysis that included all A. marginale variant and
pseudogene (donor allele) sequences in GenBank together with
those obtained during this study. These comprised 14 tick and 13
blood variants from A. marginale VA, South Idaho, and Oklahoma
strains deposited in GenBank, sequences from pseudogenes of the
sequenced genomes of A. marginale VA and South Idaho, and all
variants obtained during this study (Figure S1). One of the larger
clades (marked in the figure by the light green oval) contained the
mammalian cell culture (V2) and the tick cell culture predominant
(V1) variants, which fell into separate smaller groups. V1 grouped
with two other tick cell culture variants, while V2 associated with
variants from ticks and tick cell culture, cattle, and one of the A.
marginale VA pseudogenes. Although the two largest clades both
included variants from all sources analysed, the great majority of
tick and tick cell culture variants segregated with the clade
containing V1 and V2. 71% (10 out of 14) of the variants
generated during in vivo infection of ticks fell into this clade, and
one tick cell culture variant (V30) was an outlier unrelated to any
others (Figure S1).
Similarly, the mammalian variants obtained during culture in
endothelial and Vero cells also grouped primarily in the major
clade containing most tick variants, but did not show preferential
association with variants from any one source (Supplemental
Figure S1). Blood variants were most closely related to other blood
variants, but some were found dispersed throughout the clade
dominated by tick variants. Thus, the phylogram divides variants
into two major classes: those arising under immune selection,
showing large changes, and the others evolving without it, showing
small changes, as reflected in branch length. All except two
(VTTV106/VaE6F7 and VaP1) of the donor alleles were
positioned throughout the clade dominated by blood variants
(Figure S1).
Influence of host cell type on donor allele usage and
variant complexity
Complete genome sequencing of the St. Maries and Florida
strains reveals seven or eight msp2 pseudogenes, and that the msp2
loci are syntenic for the two strains [41]. Using these genome
sequences, a set of locus specific PCR primers were developed
(Table 3). Testing these primers on the fully sequenced St. Maries
strain did not produce artifactual chimeras. Southern analysis
indicated that A. marginale VA contained eight pseudogenes for
msp2 (Figure S2). The donor allele repertoire was determined for
Figure 2. Changes in the expression of Msp2 variants during
infection of tick and mammalian cells. (A) Detection of Msp2
variants with monospecific antibodies R884 and R883 and monoclonal
antibody O5A02 by Western blots. Controls consisted of uninfected ISE6
and IDE12 cell protein extracts. (B) Variation in recognition between
Msp2 specific antibodies using immuno fluorescence assays. Bars
length represent the percentage of A. marginale VA colonies recognized
by a monoclonal antibody or monospecific antibodies in a specific cell
line. Error bars indicate the standard deviation.
doi:10.1371/journal.pone.0036012.g002
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Examination of the A. marginale VA repertoire revealed that the
pseudogene HVRs in the loci designated VaE6F7 and Va1were
identical to the sequences in these two loci in both the St. Maries
and Florida strains, while the pseudogenes in the loci designated
Vay2, Va9H1, VaTTV106 were identical to sequences in the
Florida strain at the syntenic loci. Three novel msp2 HVR
pseudogene sequences were obtained at loci VaP1, VaG11 and
Va3H1.
Analysis of donor allele usage in populations from different cell
types showed preference for the expression of certain donor alleles
within a population (chi-square value=451.75; p#0.001). Simi-
larly, generation of variants during infection of any of the host
systems was not random (chi-square value=188.02; p#0.001). Va
TTV106/E6F7 and Va y2 were highly used during generation of
variants in vitro, being present in 94% and 50%, respectively, of
HVRs in A. marginale from tick cells, and in 89% and 44% of A.
marginale growing in mammalian cells. However Va y1 was used
preferentially during generation of variants in mammalian cells,
either by recombination of all or only portions of the pseudgene
HVR, with 44% usage compared to only 11% in tick cells
(Figure 5A and 5B). Va TTV106/E6F7, Va y2, and Va P1 donor
alleles were preferentially used in the tick systems with 97%, 87%,
and 78% representation, whereas only Va TTV106/E6F7 was
predominant in the mammalian cells system 91% (Figure 5E and
5F).
We observed differences in the representation of donor alleles in
Msp2 variants from PA344 and PA291 blood. A. marginale VA
Msp2 variants in blood from the acutely infected animal PA344
used Vay2 and VaP1 somewhat more frequently (64% and 48%,
respectively) than those from PA291 (Figure 5C). Donor allele
VaG11 was highly used (42%) in PA344 populations (Figure 5G),
while 29% and 20%, respectively, of variants expressed in both
blood samples contained Vay1 sequences. In the chronically
infected animal PA291, 30% of variants comprised Va3H1 and
were represented at 50% in the population, while VaP1 sequences
were only found in 6% of the population at 17% frequency of use
in expressed variants (Figure 5D and 5H). As in PA344 blood,
Vay2 was present in 62% of variants in the population and
contributed 62% of variant sequences (Figure 5D and 5H). By
contrast, A. marginale St. Maries predominantly utilized msp2y1 for
generation of blood variants [20], suggesting that genetic
Figure 3. Amino acid sequence alignment of predominant variants found in culture systems and blood samples. Regions that are
boxed and shaded in grey indicate conservative amino acid sequences. Conserved amino acid changes are identified by a period. Gaps represent
sites of insertions and deletions. The letters in the bottom line represent the amino acid sequence of the consensus sequence. Numbers indicate the
position of the amino acids relative to the full length expression locus sequence. V1 represents the predominant variant in tick cell cultures after 21
passages in BME26, 20 passages in DAE100T, 27 passages in ISE6, and 28 passages in IDE12 (following inoculation with cell-free bacteria). V2
corresponds to the predominant variant of tick cells at the following passages: 20 passages in Vero and 19 passages in RF/6A (following inoculation
with cell-free bacteria). All samples were taken when infections levels reached .90% at subculture. Average culture times in each cell line were 7 days
in ISE6 cells, 9 days in IDE12 cells, 12 days in DAE100T cells, 16 days in BME26 cells, 18 days in RF/6A cells, and 21 days in Vero cells.
doi:10.1371/journal.pone.0036012.g003
Figure 4. Generation of unique and shared variants during infection of blood and cell lines. Venn diagrams showing the relationship
between variants identified in cell lines and blood samples during the present study. Orange lettering identifies variants shared between mammalian
and tick cell lines, and infected bovine blood. Black lettering identifies variants that are unique to the respective cell line or blood sample, and
includes the number of variants in parentheses. Black zeros (0) represent areas of potential overlap where no shared variants were identified. V1 (in
red) is the tick predominant variant and V2 (in blue) is the mammalian predominant variant. A) Unique and shared variants in tick cell lines, B) Unique
and shared variants in tick and mammalian cell lines, and C) unique and shared variants in the tick and mammalian cell cultures, and the two blood
samples (PA291 and PA344).
doi:10.1371/journal.pone.0036012.g004
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Va9H1 was under-represented in all populations independent of
the source and whether comparing usage at the population level or
during generation of individual variants (Figure 5A–H), and this
finding is similar to that previously reported [20].
Variants from both blood samples had the highest complexity
scores at 1.5 (PA291) and 1.13 (PA344) (Figure S3), followed by
variants from mammalian cell cultures (1.1), and the tick cell
cultures presented the lowest complexity score (0.93) (Figure S3).
The low average scores in PA344 and PA291 (both of which were
splemectomized) and the cell cultures are due to the presence of
several simple variants in these samples.
Bioinformatic analysis of variant characteristics
Analysis of pI, molecular weight, charge, and hydropathicity of
the amino acid sequences of cell culture variants revealed no
correlation with host cell type. However, analysis of the predicted
secondary structure of the amino acid sequences using Psipred
identified a change in the secondary structure in Msp2 from A.
marginale VA growing in tick cell lines when compared to the most
frequent structure found in mammalian cell lines and blood.
Psipred and Chou-Fasman analyses predicted that the changes in
amino acid sequence at position 195 to 206 (relative to full length
Msp2 of A. marginale VA)from GTTNGEKVSQNV (in the tick cell
culture predominant variant) to AATNGQTVSQKV (in the
mammalian cell culture predominant variant) result in a
modification of the secondary structure of the protein in this
region (Figure 6B and C). Other amino acid changes occurred in
the sequences of these two proteins, however they did not lead to
modifications in the putative structure of the variants when
compared with one another (Figure 3). The sequence GTTN-
GEKVSQNV in the tick cell culture predominant variant was
predicted to produce an a- helix, whereas AATNGQTVSQKV in
the mammalian cell culture predominant variant would form a
b-strand. The a-helix structure was present in 44% of the variants
obtained from tick cell-grown A. marginale VA, while around 57%
of the variants from mammalian cell cultures presented the
putative b-strand structure.
Similarly, analysis of variants generated in vivo detected
structures that were more commonly expressed in either ticks or
cattle. We identified a b-strand at the sequence KISAVFSA that
was more common in blood variants (75%) than in tick variants
(56%), and sequence SKKVCKG was found in 58% of the blood
variants but in only 37% of tick variants (Figure 6A). The sequence
KELAYDTAR, generating a small helix in the HVR was present
in 81% of tick variants compared to 54% of the bovine blood
variants. Similarly, 43% of tick variants contained the helix
sequence STSGVA that appeared in only 29% of the variants
from cattle (Figure 6A). An alignment of the aa sequences of the
HVR in the predominant variants from cell cultures and bovine
blood (Figure 3, this study) revealed additional conservative and
non-conservative aa changes elsewhere (Figure 3). However, these
were not predicted to cause modifications in the putative structure
of the variants.
Relative expression of msp2
In order to determine whether the qualitative changes in msp2
expression were accompanied by quantitative changes, we
determined levels of expression of all msp2 transcripts in two tick
cell lines and one mammalian cell line (Figure 7). Data reveal
greatest transcriptional activity of msp2 in A. marginale VA growing
in ISE6 tick cells, and least in RF/6A rhesus cells, while msp2
transcription was intermediate in DAE100T cells from D. andersoni
ticks. msp2 expression during growth of A. marginale VA in ISE6
cells, when normalized against 16 s yielded a fold change of ,6
over expression in DAE100T cells (P(H1)=0.602), whereas when
normalized against rpoB, fold change less pronounced. msp2
transcript abundance in ISE6 was about twice that in RF/6A
Figure 5. Donor allele usage in Msp2 variant production by A. marginale during growth in vivo and in vitro. Each color represents the
usage of one of seven specific donor alleles (i.e. pseudogenes) during infection of a particular cell culture system, and during acute or chronic
infection in cattle. Allele usage was assessed to determine its preferential use for generation of new variants (5 A–D) and to determine its overall
representation among all variants in a population (5 E–H). The frequency of use of each allele in the production of variants was calculated from the
total number of variants that contained sequences from a specific donor allele divided by the total number of variants. This represented the
preferential usage of an allele for the production of variants and is shown in (A), for tick cell cultures; (B), mammalian cell cultures, C), acutely infected
bovine PA344; and (D), chronically infected bovine PA291. Overall allele usage in a population was calculated from the total number of clones that
comprised DNA sequence from any specific allele, divided by the total number of clones recovered from each system. This provided an estimate of
the use of an allele in any variant, whether major or minor, recovered from a population. (E), Overall usage of variants in tick cell cultures; (F), in
mammalian cell cultures; (G), in the acutely infected bovine PA344; and (H), in the chronically infected bovine 291. As an example, comparison of
corresponding pie charts A and E demonstrates that allele P1 is infrequently found in variants from tick cell cultures, although it is recovered in a large
number of clones. Whereas, a comparison of pie charts B and F shows that allele TTV106/E6F7 is recovered from mammalian cell cultures about as
often as alleles 2 and 1, although segments of TTV106/E6F7 are recovered in the majority of different clones.
doi:10.1371/journal.pone.0036012.g005
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e36012Figure 6. Changes in putative secondary structures of predominant A. marginale VA Msp2 variants in vivo and in vitro. (A) Changes in
the putative structure of Msp2 variants produced during in vivo infection of ticks and cattle. The percentages represent the predominance of the
structure in all the variants found either in experimentally infected ticks or cattle. Numbers in the parenthesis indicate the number of variants
presenting the structure divided by the total number of variants analyzed in that specific system. (B) Predicted structure of the hypervariable region
of Msp2 that predominates during infection of tick cell lines. (C) Predicted structure of the hypervariable region of Msp2 that predominates during
infection of mammalian cell lines. Symbols representing protein structure and the confidence value attributed to the accuracy of the predicted
structure are explained in the legend box.
doi:10.1371/journal.pone.0036012.g006
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negligible (P(H1)=0.181) (Figure 7). Differences in the roles (and
therefore the stability and turnover) of 16 s rRNA which serves a
structural role in the ribosome, and of mRNA for rpoB, likely are
responsible for the seeming differences in msp2 expression when
each is used as a normalizer for that gene. The statistical
significance of the analysis was affected by the variation between
samples, possibly due to the use of asynchronous cultures.
Discussion
In this study, we took advantage of the great diversity of cell
lines that support replication of A. marginale VA in order to
examine the propensity of this pathogen to undergo variation of a
major surface protein, Msp2, in response to changing host cell
environments [8,13–16]. We utilized the original culture isolate of
A. marginale VA [21] because it grows in a wide range of tick cell
lines derived from natural and experimental vectors [38,42]. In
addition, A. marginale VA readily infects and grows in at least two
mammalian cell lines as well as in primary cultures of bovine
vascular endothelial cells [28,43]. We studied the expression of
Msp2 variants of A. marginale VA in order to understand the
molecular mechanisms that underlie antigenic variation in this
organism during its residence in tick and mammalian host cells.
We demonstrated generation of predominant Msp2 variants that
differed in amino acid sequences in populations growing in specific
cell environments. Populations growing in tick cells presented
predominantly V1, a sequence that does not correspond to a
donor allele, demonstrating that the tick-adapted variant has not
been retained in the donor allele repertoire. The populations
growing in endothelial cells presented predominantly V2. In an
independent study, an A. marginale VA variant identical to V2 also
predominated in RF/6A cells as well as in bovine testicular vein
endothelial cell cultures [43], further evidence that this variant was
not randomly generated in our endothelial cell cultures.
Research with the related pathogen A. phagocytophilum that
infects neutrophil granulocytes similarly identified profound
differences in expression of Msp2 variants while residing in tick
versus mammalian cells. Unlike A. marginale, the genome of A.
phagocytophilum encodes over 100 msp2/p44 pseudogenes that are
recombined into the expression locus intact, without recombina-
tion of the HVRs [11,44]. Nonetheless, A. phagocytophilum
expression of variants changed so that major (or predominant)
variants of P44 became minor (or less frequent) variants following
transfer from mammalian hosts to ticks, or to 24uC [45], in a
manner reminiscent of antigenic variation in A. marginale. While
temperature likely is one of the factors regulating p44 expression,
other, as yet unknown biological cues derived from host and vector
tissues may induce changes in the composition of the Msp2/P44
pool expressed by Anaplasma species [45,46]. In infected ticks, the
repertoire of A. marginale variants became restricted compared to
that in the blood meal source [12,31]. Some variants expressed in
the salivary glands were identical to those in the blood stabilate
used to infect the cattle upon which the ticks had fed, but new
variants were formed as well [12,31]. In general, tick variants were
most closely related to each other, and the same was true for
mammalian variants, regardless of whether variants were
generated in vivo or in vitro (Figure S1). Because antibodies to A.
marginale were absent from our cell cultures, selection of Msp2
variants should reflect the environment provided by the specific
cell line. Thus, nearly twice as many unique variants were detected
in the four tick cell lines as in the two mammalian cell lines.
Each cell line used in this study presented differences in
morphology and biological properties that possibly affected
bacterial invasion and replication. The absence of a functional
innate immune system in ISE6 cells, which lacks phagocytic
properties and does not produce immune peptides [47], might
explain why it supported the fewest Msp2 variants. The extended
period during which A. marginale VA was propagated continuously
in ISE6 cells selected for the most suitable variants, as observed for
A. phagocytophilum [11], and at the same time favoured growth in all
tick cell lines through production of the shared predominant
variant V1. IDE12 and BME26 cells produce immune peptides
and are phagocytic [47], and DAE100T cells contain granules
resembling those present in tick salivary gland acini (A. Palmer
and T. Kurtti, unpublished results). These different environments
likely drove variation of Msp2 in A. marginale VA, and similar
mechanisms could facilitate invasion and exploitation of different
hosts and tissues. The increased number of variants observed in
the mammalian versus the tick cell lines could reflect their origin
from primates, which are naturally resistant, but at the same time
highlights the adaptive potential of A. marginale. Nonetheless,
growth of A. marginale VA in primary bovine vascular endothelial
cells generated the same dominant Msp2 variant as did growth in
the rhesus microvascular endothelial cell line RF/6A and in Vero
cells [43]. This result, together with evidence that A. marginale VA
may infect bovine microvascular endothelium in vivo [48], validates
the use of RF/6A cells to model A. marginale infection of bovine
cells.
Based on a comparison with other gram-negative bacteria and
characteristics such as outer membrane localization and predicted
amphipathic and antiparallel ß-strand structures, it was suggested
that Msp2/P44 of A. phagocytophilum acted as a porin [18]. The
amino acid sequence GTTNGEKVSQNV (Figure 6 C) was
predicted to result in formation of a b-strand (Chou-Fasman
method and Psipred), and this sequence predominated during
growth in mammalian cells. This sequence was not present during
infection of tick cells indicated the corresponding structure was not
required. Similarly, our analysis of variants in vivo demonstrated b-
strands in bovines and helices primarily in ticks. An analysis of
pseudogene usage in cattle infected with the St. Maries strain of A.
marginale likewise revealed that an allele, msp2y1, encoding a b-
strand, was significantly overrepresented [20], further supporting
selection of these structures in the mammalian host.
Figure 7. Relative expression of msp2 during infection of tick
and mammalian cell lines. Bar length represents the fold change in
expression of msp2 during A. marginale VA infection of ISE6 vs
DAE100T, ISE6 vs RF/6A, DAE100T vs RF/6A, using rpoB (bars in blue)
and 16s rRNA (bars in red) as normalizers. Relative expression was
calculated using the comparative Ct method (2
2DDCt) [36]. Bars
represent the fold values calculated with the mean Ct values.
doi:10.1371/journal.pone.0036012.g007
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populations differs among A. marginale VA from cattle, and tick
versus mammalian cell lines (Figure 4). Although V1 and V2 are
both present in cell lines and blood, V1 is dominant only in tick
cells, and V2 only in mammalian cells, including bovine blood. In
addition to dominant variants, each environment provokes
generation of minor variants, creating unique profiles. Generation
and selection of Msp2 variants is thought to be governed in part by
the fitness they impart to the organism, with simple variants
favored as long as immune pressure does not eliminate them [20].
We hypothesized that this should be reflected in the degree of msp2
expression, and indeed, msp2 transcripts were most abundant in
ISE6 tick cells (Figure 7) in which variants also had the lowest
complexity scores (Figure S3). When we compared donor allele
usage during infection of bovine blood and the two in vitro systems
(mammalian and tick cells), we found that certain donor alleles
were preferentially used in populations to generate new variants.
Three donor alleles in particular, i.e., VaTTV106/E6F7, VaP1,
and Vay2, were the source of variants generated in ticks. This
strengthens the hypothesis that certain donor alleles or variants
provide a fitness advantage to the organism when infecting specific
host systems, and consequently become predominant through
selection [20].
This study further elucidates the molecular mechanisms that
underlie antigenic variation in A. marginale as it cycles through
ticks and mammals. The conformational changes induced in
Msp2 in response to host cell environment offer insight into the
role of this molecule beyond that in immune-evasion. In this
regard, susceptible mammalian cell lines complement the use of
tick cell lines. However, conclusions about the function of Msp2
should not be driven only by predictions of the secondary
structure, and studies to determine the precise function of Msp2
are necessary.
Conclusions
Our analysis of the development of A. marginale VA in vitro
revealed complex changes following transfer from tick to
mammalian cell lines similar to those that occur during its life
cycle. A. marginale VA grew in two mammalian and four tick cell
lines producing strikingly different colonies in each. The
expression of specific Msp2 variants depended on the host cell
type and resulted in changes in Msp2 detected by reactivity with
specific antibodies. Molecular analysis showed predominant
expression of Msp2 variant V1 in ticks and tick cell lines, whereas
Msp2 variant V2 predominated in mammalian cell lines. Msp2 V1
differed in 9 amino acids from V2. Further, analysis of Msp2
variation during in vitro growth of A. marginale VA in tick and
endothelial cells demonstrated the ability of the organism to
generate unique variants present only in specific cell lines.
Selection for variants presenting a specific secondary structure
predicted by Psipred in the HVR of Msp2 during infection of
cattle and ticks in vivo was supported by generation of the same
structures in mammalian versus tick cell lines in vitro. Populations of
A. marginale VA preferentially utilized certain msp2 alleles for
generation of Msp2 variants during development in tick and
mammalian cell lines in a manner consistent with what was seen in
ticks and cattle. The selection of bacteria presenting a specific
structure in the Msp2 protein suggests that this protein plays an
important role in the ability of A. marginale to infect and survive in
divergent hosts. Relative expression of msp2 did not significantly
differ depending on the cell line in which A. marginale VA grew, as
shown by qRT-PCR results. These findings underscore the
putative divergent functions of Msp2 in the vector as opposed to
the mammal, as well as the need to define the function of this
protein.
Supporting Information
Figure S1 Phylogram of Msp2 variants generated in
vivo and in vitro. Neighbor joining tree generated using the
amino acid sequences of the Msp2 HVR from several variants
obtained during infection of Dermancentor spp. ticks, bovine hosts, and
tick and mammalian cell cultures with several strains of A. marginale.
HVRs are designated by their GenBank Accession numbers, along
with the HVR from variants obtained in this study, designated by
their variant code (e.g. V1, V2, etc). Variants generated during
infection of salivary glands of ticks in vivo or during in vitro culture of
A. marginale in tick cell lines are presented in light green.
Predominant tick variant (V1) is shown in dark green and indicated
by a green arrow. Variants marked with an asterisk (*) represent
GenBank Msp2 sequences from A. marginale VA. Variants produced
during acute phases of bovine infection in erythrocytes are shown in
dark blue and those generated later during the persistent phase, or
chronic infection, are shown in light blue. Mammalian cell culture
variants are shown in purple. V2 is shown in dark purple and
indicated by a purple arrow. Donor allele sequences are marked in
red letters. Variants shared between the tick and mammalian cell
cultures are shown in orange. Branch lengths show the number of
amino acid changes between the variants. Values next to branches
correspond to 3000 bootstrap analyses using MEGA 4.0. Only
branches with over 50 percentage support are indicated in the tree.
Vertical bar in lower right represents five amino acid changes.
(TIF)
Figure S2 Genomic Southern analysis of msp2. Lane M
contains labeled lambda-HindIII markers with sizes (in kbp)
indicated to the left, lanes StM and Va contain FspI digested
genomic DNA from the St. Maries and A. marginale VA,
respectively. The expression site is indicated (ES).
(TIF)
Figure S3 Changes in Msp2 complexity scores during
infection of four different systems. Complexity was
measured by determining the number of expression site segments
derived from one of the eight different donor msp2 alleles encoded
in the genome of A. marginale VA. Bars represent the average of the
complexity score in a chronically infected animal (PA291), an
acutely infected animal (PA344), and during culture in tick and
mammalian cells. Lines represent the standard deviation of the
mean. ‘‘n’’ stands for the number of variants present in each
population that was used to calculate complexity scores.
(TIF)
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